Blonder Tongue Laboratories Inc
BDR was delisted on the 24th of June, 2022.
5 hedge funds and large institutions have $276K invested in Blonder Tongue Laboratories Inc in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
26% more capital invested
Capital invested by funds: $219K → $276K (+$57K)
25% more funds holding
Funds holding: 4 → 5 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tufton Capital Management
Hunt Valley,
Maryland
|
+$54.3K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.55K |
BDR Hedge Fund Activity: Q2 2014 in Review
5 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q2 2014, worth a combined $276K — up 26% from $219K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BDR positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Tufton Capital Management, opening a new position worth an estimated $54.3K. The largest seller was Citadel Advisors, cutting an estimated $2.55K.
- 5 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q2 2014, up from 4 in Q1 2014.
- Funds reported $276K of Blonder Tongue Laboratories Inc stock for Q2 2014, up 26% quarter-over-quarter.
- 2 funds opened new Blonder Tongue Laboratories Inc positions in Q2 2014 and 1 closed out, a net change of +1 holder.
- The largest Blonder Tongue Laboratories Inc buyer in Q2 2014 was Tufton Capital Management, an estimated $54.3K added.
- The largest Blonder Tongue Laboratories Inc seller in Q2 2014 was Citadel Advisors, an estimated $2.55K sold.
Based on aggregated 13F filings for Q2 2014.